Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Sweeping U.S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a chilling effect on vaccine makers as ...
Zacks Investment Research on MSN
Novavax grants license for use of Matrix-M adjuvant to Pfizer
Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...
Buying into it will quickly have you invested in 100 companies with at least 10 years of dividend increases. Top holdings ...
Find Antibody Test Latest News, Videos & Pictures on Antibody Test and see latest updates, news, information from NDTV.COM. Explore more on Antibody Test.
Novavax, the Covid-19 vaccine maker, has licensed the rights for a vaccine-enhancing component to Pfizer. Pfizer agreed to pay $30 million upfront, and could pay up to $500 million more if development ...
Novavax is eligible to receive tiered royalties in the high mid-single digit range on sales of any Pfizer products that use Matrix-M. Novavax, Inc. (NVAX) shares climbed 6% higher in pre-market ...
A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...
10d
BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan
BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...
Most people who were initially hesitant about getting vaccinated against Covid-19 eventually received the jab, an ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results